Track topics on Twitter Track topics that are important to you
BioSig Technologies (OTCQB:BSGM, OTCQB:BSGMD), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, announced that its shares of common stock have been approved for trading on the Nasdaq Capital Market, commencing on Friday, September 21. As quoted in the … Continued
The post BioSig Technologies to Commence Trading on the Nasdaq appeared first on Investing News Network.
Original Article: BioSig Technologies to Commence Trading on the NasdaqNEXT ARTICLE
The role of medical devices in healthcare is essential. The diversity and innovativeness of this sector contribute significantly to enhance the quality and efficacy of healthcare. Covering a wide range of products, from simple bandages to the...